Wildcat Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Hold |
|
|||||
|
2025
Q1 | $4.26M | Hold |
|
|||||
|
2024
Q4 | $6.22M | Hold |
|
|||||
|
2024
Q3 | $8.18M | Hold |
|
|||||
|
2024
Q2 | $6.81M | Buy |
|
|||||
|
2024
Q1 | $7.88M | Hold |
|
|||||
|
2023
Q4 | $6.17M | Hold |
|
|||||
|
2023
Q3 | $6.09M | Hold |
|
|||||
|
2023
Q2 | $9.55M | Hold |
|
|||||
|
2023
Q1 | $9.49M | Sell |
|
|||||
|
2022
Q4 | $13.4M | Hold |
|
|||||
|
2022
Q3 | $23M | Hold |
|
|||||
|
2022
Q2 | $24.3M | Hold |
|
|||||
|
2022
Q1 | $19.4M | Buy |
|
|||||
|
2021
Q4 | $25.6M | Hold |
|
|||||
|
2021
Q3 | $44.1M | Hold |
|
|||||
|
2021
Q2 | $44.8M | Buy |
|
|||||
|
2021
Q1 | $53.5M | Hold |
|
|||||
|
2020
Q4 | $38.3M | Hold |
|
|||||
|
2020
Q3 | $57.1M | Hold |
|
|||||
|
2020
Q2 | $64.9M | Buy |
|
|||||
|
2020
Q1 | $26.2M | Buy |
|
|||||
|
2019
Q4 | $31.2M | Buy |
|
|||||
|
2019
Q3 | $24.7M | Buy |
|
|||||
|
2019
Q2 | $14.3M | Buy |
|